LIANY
Lianbio
Biopharmaceutical company developing and commercializing medicines for cardiovascular, oncology, ophthalmology, and inflammatory diseases
ADRUnderlying: LIANYCUSIP: 53000N108HealthcareCN1 holder
Sponsored ADR — Delisted from Nasdaq, shut down operations in 2024
Total Value
$8.13M
Total Shares
3.56M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$8.13M3.56M sharesUnchanged